Analyst Ratings For NASDAQ:CLLS – Cellectis (NASDAQ:CLLS)
Today, Oppenheimer raised its price target on NASDAQ:CLLS – Cellectis (NASDAQ:CLLS) to per share.
Some recent analyst ratings include
- 3/16/2018-Guggenheim initiated coverage with a Neutral ➝ Neutral rating.
- 10/29/2017-Jefferies Financial Group Reiterated Rating of Buy.
- 10/6/2017-SunTrust Banks Reiterated Rating of Hold.
- 9/5/2017-Wells Fargo & Co Reiterated Rating of Outperform ➝ Outperform.
- 3/1/2017-Instinet initiated coverage with a Buy ➝ Buy rating.
Recent Trading Activity for NASDAQ:CLLS – Cellectis (NASDAQ:CLLS)
Shares of NASDAQ:CLLS – Cellectis closed the previous trading session at 30.53 up +0.32 1.06% with 30.610000610351562 shares trading hands.